The Mechanism of Action of Nitro-heterocyclic Antimicrobial Drugs. Metabolic Activation by Micro-organisms

References

1. Asnis R. E., Cohen F. B., Gots J. S. 1952; Studies on bacterial resistance to furacin. Antibiotics and Chemotherapy 2:123–129
   [Google Scholar]
2. Assandri A., Lancini G. C., Volpe G., Cavalleri B. 1976; New nitroimidazole derivative with antibacterial activity. Belgian Patent 837:595
   [Google Scholar]
3. Bambury R. E., Lutz C. M., Miller L. F., Kim H. K., Ritter H. W. 1973; Nitrones. 6. α-(5-Nitroimidazol-2-yl)-N-substituted nitrones. Journal of Medicinal Chemistry 16:566–568
   [Google Scholar]
4. Beckett A. H., Robinson A. E. 1956; The reactions of antibacterial substances with bacteria.Part I. Methods using nitrofurazone and Aerobacter aerogenes . Journal of Pharmacy and Pharmacology 8:1072–1085
   [Google Scholar]
5. Beckett A. H., Robinson A. E. 1959; The reactions of nitrofurans with bacteria. II. Reduction of a series of nitrofurans by Aerobacter aerogenes . Journal of Medicinal and Pharmacological Chemistry 1:135–154
   [Google Scholar]
6. Brezina M., Zuman P. 1958 Polarography in Medicine, Biochemistry and Pharmacy. New York: Interscience;
   [Google Scholar]
7. Brown N. C., Wisseman C. L. III Matsushita T. 1972; Inhibition of bacterial DNA replication by 6-(p-hydroxyphenylazo)-uracil. Nature New Biology 237:72–74
   [Google Scholar]
8. Burgess R. R. 1969; A new method for the large scale purification of Escherichia coli deoxyribonucleic acid-dependent ribonucleic acid polymerase. The Journal of Biological Chemistry 244:6160–6167
   [Google Scholar]
9. Cartwright N. J., Cain R. B. 1959; Bacterial degradation of the nitrobenzoic acids. 2. Reduction of the nitro group. Biochemistry 73:305–314
   [Google Scholar]
10. Cavalleri B., Ballotta R., Arioli V. 1971; Schiff bases from 2-aminoimidazoles. Chimie Therapeutique 6:397–402
    [Google Scholar]
11. Cavalleri B., Ballotta R., Lancini G. C. 1972; Synthesis of l-alkyl-2-nitroimidazole-5-carboxalde-hydes. Journal of Heterocyclic Chemistry 9:979–984
    [Google Scholar]
12. Cavalleri B., Ballotta R., Arioli V., Lancini G. C. 1973; New 5-substituted 1-alkyl-2-nitroimi-dazoles. Journal of Medicinal Chemistry 16:557–560
    [Google Scholar]
13. Cavalleri B., Arioli V., Lancini G. C. 1974; Synthesis and antimicrobial activity of 2-nitroimidazoIes substituted in position 5. Progress in Chemotherapy, Proceedings of the Eighth International Congress of Chemotherapy (Athens, 1974) 2 pp. 560–565 Daikos G. K. Edited by Athens: Hellenic Society for Chemotherapy;
    [Google Scholar]
14. Cavalleri B., Ballotta R., Arioli V. 1975; i-alkyl-2-nitroimidazol-5-yl derivatives. Arzneimittel-Forschung 25:338–340
    [Google Scholar]
15. Clark A. J., Chamberlin M., Boyce R. P., Howard-Flanders P. 1966; Abnormal metabolic response to ultraviolet light of a recombination deficient mutant of Escherichia coli K12. Journal of Molecular Biology 19:442–454
    [Google Scholar]
16. Cramer D. L. 1947; Mode of action of nitrofuran compounds. II. Application of physicochemical methods to the study of action against Staphylococcus aureus . Journal of Bacteriology 54:119–125
    [Google Scholar]
17. Dann O., MÖller E. F. 1947; Bakteriostatisch wirkende Nitro-Verbindungen des Thiophens und Furans. Chemische Berichte 80:23–36
    [Google Scholar]
18. Dann O., MÖller E. F. 1949; Uber die wachstumshemmenden Eigenschaften von Nitroverbindungen. Chemische Berichte 82:76–94
    [Google Scholar]
19. Davis B. D., Mingioli E. S. 1950; Mutants of Escherichia coli requiring methionine or vitamin B12. Journal of Bacteriology 60:17–28
    [Google Scholar]
20. Edwards D. I., Dye M., Carne H. 1973; The selective toxicity of antimicrobial nitroheterocyclic drugs. Journal of General Microbiology 76:135–145
    [Google Scholar]
21. Glaser J. H., DeMoss J. A. 1971; Phenotypic restoration by molybdate of nitrate reductase activity in chlD% mutants of Escherichia coli . Journal of Bacteriology 108:854–860
    [Google Scholar]
22. Goldstein B. P., Nielsen E., Berti M., Bolzoni G., Silvestri L. G. 1977; The mechanism of action of nitro-heterocyclic antimicrobial drugs. Primary target of i-methyl-2-nitro-5-vinylimidazole is DNA. Journal of General Microbiology 100:271–281
    [Google Scholar]
23. Grunberg E., Titsworth E. H. 1973; Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings. Annual Reviews of Microbiology 27:317–346
    [Google Scholar]
24. Henry D. W., Hoff D. R. 1965; i-substituted-2-acyl-5-nitroimidazoles. Belgian Patent 661:262
    [Google Scholar]
25. Hoffer M., Macdonald A. Jr 1972; i-Methyl-2-substituted 5-nitroimidazoles. U.S. Patent 3:652–579
    [Google Scholar]
26. Ings R. M. J., Mcfadzean J. A., Ormerod W. E. 1974; The mode of action of metronidazole in Trichomonas vaginalis and other microorganisms. Biochemical Pharmacology 23:1421–1429
    [Google Scholar]
27. Kohiyama M., Kolber A. R. 1970; Temperature sensitive mutant of the DNA replication system in Escherichia coli . Nature; London: 2281157–1160
    [Google Scholar]
28. Kolthoff J. M., Lingane J. J. 1952 Polarography. New York: Interscience;
    [Google Scholar]
29. Lancini G. C., Lazzari E. 1965; The synthesis of azomycin. Experientia 21:83
    [Google Scholar]
30. Lancini G. C., Lazzari E., Arioli V., Bellani P. 1969; Synthesis and relationship between structure and activity of 2-nitroimidazole derivatives. Journal of Medicinal Chemistry 12:775–780
    [Google Scholar]
31. Lawson A. 1956; The reaction of cyanamide with α-amino-acetals and α-amino-aldehydes. Journal of the Chemical Society307–310
    [Google Scholar]
32. Mccalla D. R. 1965; Nitrofuran derivatives as radiomimetic agents: cross-resistance studies with Escherichia coli . Canadian Journal of Microbiology 11:185–191
    [Google Scholar]
33. Mccalla D. R., Reuvers A., Kaiser C. 1970; Mode of action of nitrofurazone. Journal of Bacteriology 104:1126–1134
    [Google Scholar]
34. Miller J. H. 1972 Experiments in Molecular Genetics. Cold Spring Harbor: Cold Spring Harbor Laboratory;
    [Google Scholar]
35. Paul H. E., Ells V. R., Kopko F., Bender R. C. 1960; Metabolic degradation of the nitrofurans. Journal of Medicinal and Pharmaceutical Chemistry 2:563–584
    [Google Scholar]
36. Payne J. I., Hartman P. E., Mudd S., Phillips A. W. 1956; Cytological analysis of ultraviolet-irradiated Escherichia coli. III. Reactions of a sensitive strain and its resistant mutants. Journal of Bacteriology 72:461–472
    [Google Scholar]
37. Saeki T., Umezawa H., Tokieda-Fujishige T., Hori M. 1974; Biological effects of azomycin (2-nitroimidazole) : inhibition of ribonucleoside reductase. Journal of Antibiotics 27:225–227
    [Google Scholar]
38. Szybalski W., Nelson T. C. 1954; Genetics of bacterial resistance to nitrofurans and radiation. Bacteriological Proceedings 1954:51–52
    [Google Scholar]
39. Taylor A. L., Trotter C. D. 1972; Linkage map of Escherichia coli strain K12. Bacteriological Reviews 36:504–524
    [Google Scholar]
40. Tu Y., Mccalla D. R. 1975; Effect of activated nitrofurans on DNA. Biochimica et biophysica acta 402:142–149
    [Google Scholar]
41. Venables W. A., Guest J. R. 1968; Transduction of nitrate reductase loci of Escherichia coli by P1 and λ . Molecular and General Genetics 103:127–140
    [Google Scholar]
42. Wimpenny J. W. T., Cole J. A. 1967; The regulation of metabolism in facultative bacteria. III. The effect of nitrate. Biochimica et biophysica acta 148:233–242
    [Google Scholar]
43. Woody-Karrer P., Greenberg J. 1963; Resistance and cross-resistance of Escherichia coli s mutants to the radiomimetic agent nitrofurazone. Journal of Bacteriology 85:1208–1216
    [Google Scholar]
44. Yahagi T., Nagao M., Kazuko H., Matsushima T., Sugimura T., Byran G. T. 1974; Relationships between the carcinogenic and mutagenic or DNA-modifying effects of nitrofuran derivatives, including 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide, a food additive. Cancer Research 34:2266–2273
    [Google Scholar]